Hsien-Yi Chiu. (2017). An investigator-initiated, open-label, single-center, proof-of-concept-study of omalizumab in patients with poorly controlled acute urticaria. Wolters Kluwer Medknow Publications.
Chicago Style (17th ed.) CitationHsien-Yi Chiu. An Investigator-initiated, Open-label, Single-center, Proof-of-concept-study of Omalizumab in Patients with Poorly Controlled Acute Urticaria. Wolters Kluwer Medknow Publications, 2017.
MLA (9th ed.) CitationHsien-Yi Chiu. An Investigator-initiated, Open-label, Single-center, Proof-of-concept-study of Omalizumab in Patients with Poorly Controlled Acute Urticaria. Wolters Kluwer Medknow Publications, 2017.
Warning: These citations may not always be 100% accurate.